UK markets closed
  • FTSE 100

    7,177.78
    +118.33 (+1.68%)
     
  • FTSE 250

    22,912.30
    +392.58 (+1.74%)
     
  • AIM

    1,197.13
    +9.57 (+0.81%)
     
  • GBP/EUR

    1.1754
    +0.0028 (+0.24%)
     
  • GBP/USD

    1.3315
    +0.0014 (+0.11%)
     
  • BTC-GBP

    44,078.09
    +790.21 (+1.83%)
     
  • CMC Crypto 200

    1,496.91
    +27.83 (+1.89%)
     
  • S&P 500

    4,646.81
    +79.81 (+1.75%)
     
  • DOW

    34,936.13
    +452.41 (+1.31%)
     
  • CRUDE OIL

    68.27
    +2.09 (+3.16%)
     
  • GOLD FUTURES

    1,786.40
    +9.90 (+0.56%)
     
  • NIKKEI 225

    27,935.62
    +113.86 (+0.41%)
     
  • HANG SENG

    23,658.92
    +183.66 (+0.78%)
     
  • DAX

    15,496.60
    +396.47 (+2.63%)
     
  • CAC 40

    6,901.44
    +180.28 (+2.68%)
     

Global Human Microbiome Therapeutics Market 2021-2027: Including Profiles of Bristol-Myers Squibb, Vertex Pharmaceuticals, Puretech Health and Pfizer

·2-min read

Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Human Microbiome Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global human microbiome therapeutics market is expected to grow at a CAGR of around 42.7% during 2021-2027.

This report on global human microbiome therapeutics market report provides a holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.

The report presents a clear picture of the global human microbiome therapeutics market by segmenting the market based on technology, therapeutic area, type, and region.

Also, detailed profiles of companies operating in the human microbiome therapeutics market are provided in this report.

Companies Mentioned

  • Bristol-Myers Squibb

  • Dow Inc Chemical

  • Takeda Pharmaceutical Company Limited

  • Johnson & Johnson

  • DuPont de Nemours, Inc.

  • Merck & Co. Inc.

  • Pfizer Inc.

  • Vertex Pharmaceuticals

  • Evelo Biosciences, Inc.

  • Kaleido Biosciences, Inc.

  • Seres Therapeutics, Inc.

  • PureTech Health PLC

Market Drivers

  • Human Microbiome as a Validated Target for Drug Development

  • Increasing Focus on Human Microbiome Therapeutics Development

  • Increasing Collaboration Between Public-Private Organizations

Market Challenges

  • Stringent Government Regulations

  • Lack of Expertise and Adequate Research

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027

Market by Technology

  • Genomics

  • Proteomics

  • Metabolomics

Market by Route of Therapeutic Area

  • Neurological Disorders

  • Dermatological Indications

  • Cancers

  • Metabolic Disorders

  • Gastrointestinal Disorders

  • Others

Market by Type

  • Probiotics and Prebiotics

  • Medical Food

  • Diagnostic Tests

  • Others

Market by Region

  • Europe

  • North America

  • Asia Pacific

  • Latin America

  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/thkrue

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting